Immune evasion by gammaherpesvirus genome maintenance proteins

Journal of General Virology

Volumn 91, Issue 4, 2010, Pages 829-846

  Blake, Neil ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; EPSTEIN BARR VIRUS ANTIGEN 1; GAMMA INTERFERON; GENOME MAINTENANCE PROTEIN; GLUTAMIC ACID; GLUTAMINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; BURKITT LYMPHOMA; CARBOXY TERMINAL SEQUENCE; CARNIVORE; CD8+ T LYMPHOCYTE; CELL SURFACE; CODON; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ENZYME LINKED IMMUNOSPOT ASSAY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE SEQUENCE; HERPES VIRUS; HODGKIN DISEASE; HOST CELL; HUMAN HERPESVIRUS 8; IMMUNE SYSTEM; IMMUNOSURVEILLANCE; LYMPHOCYTE; MACAVIRUS; MONONUCLEOSIS; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PERCAVIRUS; PERISSODACTYLA; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW; RHADINOVIRUS; SEROCONVERSION; SEROPREVALENCE; VIRUS GENE; VIRUS GENOME; VIRUS IDENTIFICATION; VIRUS INFECTION;

ANIMALS; ANTIGENS, VIRAL; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GAMMAHERPESVIRINAE; GENOME, VIRAL; HUMANS; IMMUNE EVASION; NUCLEAR PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS; VIRUS LATENCY;

HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8;

EID: 77949522810     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.018242-0     Document Type: Review

References (149)

1. Albrecht, J.-C. (2000). Primary structure of the Herpesvirus ateles genome. J Virol 74, 1033-1037.
2. Albrecht, J.-C., Nicholas, J., Biller, D., Cameron, K. R., Biesinger, B., Newman, C., Wittman, S., Craxton, M. A., Coleman, H. & other authors (1992). Primary structure of the herpesvirus saimiri genome. J Virol 66, 5047-5058.
3. Alexander, L., Denekamp, L., Knapp, A., Auerbach, M. R., Damania, B. & Desrosiers, R. C. (2000). The primary sequence of rhesus monkey rhadinovirus isolate 26-95: sequence similarities to Kaposi's sarcoma-associated herpesvirus and rhesus rhadinovirus isolate 17577. J Virol 74, 3388-3398.
4. Allen, R. D., Dickerson, S. & Speck, S. H. (2006). Identification of spliced gammaherpesvirus 68 LANA and v-cyclin transcripts and analysis of their expression in vivo during latent infection. J Virol 80, 2055-2062.
5. Apcher, S., Komarova, A., Daskalogianni, C., Yin, Y., Malbert-Coas, L. & Frahaeus, R. (2009). mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1. J Virol 83, 1289-1298.
6. Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C. & other authors (1984). DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207-211.
7. Ballestas, M. E. & Kaye, K. W. (2001). Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J Virol 75, 3250-3258.
8. Ballestas, M. E., Chatis, P. A. & Kaye, K. M. (1999). Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284, 641-644.
9. Barbera, A. J., Ballestas, M. E. & Kaye, K. M. (2004). The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 N terminus is essential for chromosome association, DNA replication, and episomal maintenance. J Virol 78, 294-301.
10. Barbera, A. J., Chodaparambil, J. V., Kelley-Clarke, B., Joukov, V., Walter, J. C., Luger, K. & Kaye, K. M. (2006). The nucleosomal surface as a docking system for Kaposi's sarcoma herpesvirus LANA. Science 311, 856-861.
11. Bennett, N. J., May, J. S. & Stevenson, P. (2005). Gamma-herpesvirus latency requires T cell evasion during episome maintenance. PLoS Biol 3, e120.
12. Biesinger, B., Trimble, J. J., Desrosiers, R. C. & Fleckenstein, B. (1990). The divergence between two oncogenic herpesvirus saimiri strains in a genomic region related to the transforming phenotype. Virology 176, 505-514.
13. Biesinger, B.,Muller-Fleckenstein, I., Simmer, B., Lang, G., Wittman, S., Plazter, E., Desrosiers, R. C. & Fleckenstein, B. (1992). Stable growth transformation of human T lymphocytes by Herpesvirus saimiri. Proc Natl Acad Sci U S A 89, 3116-3119.
14. Bihl, F., Naranyan, M., Chisholm, J. V., III, Henry, L. M., Suscovich, T. J., Brown, E. E., Welzel, T. M., Kaufmann, D. E., Zaman, T. M. & other authors (2007). Lytic and latent antigens of the human gammaherpesvirus Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus induce T-cell responses with similar functional properties and memory phenotypes. J Virol 81, 4904-4908.
15. + T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Immunity 7, 791-802.
16. Blake, N. W., Moghaddam, A., Roa, P., Kaur, A., Glickman, R., Cho, Y.-G., Marchini, A., Haigh, T., Johnson, P. & other authors (1999). Inhibition of antigen presentation by the glycine/alanine repeat domain of the Epstein-Barr virus nuclear antigen 1 homologue is not essential for persistent infection by baboon and rhesus lymphocryptoviruses. J Virol 73, 7381-7389.
17. Blake, N., Haigh, T., Shaka'a, G., Croom-Carter, D. & Rickinson, A. (2000). The importance of exogenous antigen in priming the human CD8+ T cell responses: lessons from the EBV nuclear antigen, EBNA1. J Immunol 165, 7078-7087.
18. Blasdell, K., McCracken, C., Morris, A., Nash, A. A., Begon, M., Bennett, M. & Stewart, J. P. (2003). The wood mouse is a natural host for Murid herpesvirus 4. J Gen Virol 84, 111-113.
19. Brander, C., Raje, N., O'Connor, P. G., Davies, F., Davis, J., Chauhan, D., Hideshima, T., Martin, J., Osmond, D. & other authors (2002). Absence of biologically important Kaposi's sarcoma-associated herpesvirus gene products and virus-specific cellular immune responses in multiple myeloma. Blood 100, 698-700.
20. Burnside, K. L., Ryan, J. T., Bielefeldt-Ohmann, H., Bruce, A. G., Thouless, M. E., Tsai, C.-C. & Rose, T. M. (2006). RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed retroperitoneal fibromatosis (RF) tumor cells. Virology 354, 103-115.
21. Calderwood, M. A., Hall, K. T., Matthews, D. A. & Whitehouse, A. (2004). The herpesvirus saimiri ORF73 gene product interacts with host-cell mitotic chromosomes and self-associates via its C terminus. J Gen Virol 85, 147-153.
22. Calderwood, M., White, R. E., Griffiths, R. A. & Whitehouse, A. (2005). Open reading frame 73 is required for herpesvirus saimiri A11-S4 episomal persistence. J Gen Virol 86, 2703-2708.
23. Cesarman, E., Chang, Y., Moore, P. S., Said, J. W. & Knowles, D. M. (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332, 1186-1191.
24. Chang, Y. & Moore, P. S. (1996). Kaposi's sarcoma (KS)-associated herpesvirus and its role in KS. Infect Agents Dis 5, 215-222.
25. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M. & Moore, P. S. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-1869.
26. Chang, Y., Moore, P. S., Talbot, S. J., Boshoff, C. H., Zarkowska, T., Godden, K., Paterson, H., Weiss, R. A. & Mittnacht, S. (1996). Cyclin encoded by KS herpesvirus. Nature 382, 410.
27. Cho, Y.-G., Ramer, J., Rivailler, P., Quink, C., Garber, R. L., Beier, D. R. & Wang, F. (2001). An Epstein-Barr virus-related herpesvirus from marmoset lymphomas. Proc Natl Acad Sci U S A 98, 1224-1229.
28. Coleman, H. M., Efstathiou, S. & Stevenson, P. G. (2005). Transcription of the murine gammaherpesvirus 68 ORF73 from promoters in the viral repeats. J Gen Virol 86, 561-574.
29. Collins, C. M., Medveczky, M. M., Lund, T. & Medveczky, P. G. (2002). The terminal repeats and latency-associated nuclear antigen of herpesvirus saimiri are essential for episomal persistence of the viral genome. J Gen Virol 83, 2269-2278.
30. Cossee, M., Campuzano, V., Koutnikova, H., Fishbeck, K., Mandel, J. L., Koenig, M., Bidichandani, S. I., Patel, P. I., Molto, M. D. & other authors (1997). Frataxin fracas. Nat Genet 15, 337-338.
31. Cotter, M. A. & Robertson, E. S. (1999). The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264, 254-264.
32. Cotter, M. A., Subramanian, C. & Robertson, E. S. (2001). The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus. Virology 291, 241-259.
33. Cristillo, A. D., Mortimer, J. R., Barratte, I. H., Lillicrap, T. P. & Forsdyke, D. R. (2001). Double-stranded RNA as a not-self alarm signal: to evade, most viruses purine-load their RNAs but some (HTLV-1, Epstein-Barr) pyrimidine-load. J Theor Biol 208, 475-491.
34. Damania, B. & Desrosiers, R. C. (2001). Simian homologues of human herpesvirus 8. Philos Trans R Soc Lond B Biol Sci 356, 535-543.
35. Daskalogianni, C., Apcher, S., Candeias, M. M., Naski, N., Calvo, F. & Fahraeus, R. (2008). Gly-Ala repeats induce position and substrate specific regulation of 26S proteasome-dependent partial processing. J Biol Chem 283, 30090-30100.
36. Davison, A. J., Eberle, R., Ehlers, B., Hayward, G. S., McGeoch, D. J., Minson, A. C., Pellet, P. E., Roizman, B., Studdert, M. J. & Thiry, E. (2009). The order Herpesvirales. Arch Virol 154, 171-177.
37. Day, L., Chau, C. M., Nebozyhyn, M., Rennekamp, A. J., Showe, M. & Liberman, P. M. (2007). Chromatin profiling of Epstein-Barr virus latency control region. J Virol 81, 6389-6401.
38. DeWire, S. M. & Damania, B. (2005). The latency-associated nuclear antigen of rhesus monkey rhadinovirus inhibits replication through repression of ORF50/Rta transcriptional activation. J Virol 79, 3127-3138.
39. Dittmer, D., Lagunoff, M., Renne, R., Staskus, K., Haase, A. & Ganem, D. (1998). A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 72, 8309-8315.
40. Duboise, S. M., Guo, J., Czajak, S., Desrosiers, R. C. & Jung, J. U. (1998). STP and TIP are essential for herpesvirus saimiri oncogenicity. J Virol 72, 1308-1313.
41. Ensser, A., Pflanz, R. & Fleckenstein, B. (1997). Primary structure of the alcelaphine herpesvirus 1 genome. J Virol 71, 6517-6525.
42. Ensser, A., Thurau, M., Wittmann, S. & Fickenscher, H. (2003). The genome of herpesvirus saimiri C488 which is capable of transforming human T cells. Virology 314, 471-487.
43. Falk, K., Gratama, J. W., Rowe, M., Zou, J. Z., Khanim, F., Young, L. S., Oosterveer, M. A. & Ernberg, I. (1995). The role of repetitive DNA sequences in the size variation of Epstein-Barr virus (EBV) nuclear antigens, and the identification of different EBV isolates using RFLP and PCR analysis. J Gen Virol 76, 779-790.
44. Feeney, K. M. & Parish, J. L. (2009). Targeting mitotic chromosomes: a conserved mechanism to ensure viral genome persistence. Proc Biol Sci 276, 1535-1544.
45. Fickenscher, H. & Fleckenstein, B. (2001). Herpesvirus saimiri. Philos Trans R Soc Lond B Biol Sci 356, 545-567.
46. Fickenscher, H., Biesinger, B., Knappe, A., Wittman, S. & Fleckenstein, B. (1996). Regulation of the herpesvirus saimiri oncogene stpC, similar to that of the T-cell activation genes, in growth transformed human T lymphocytes. J Virol 70, 6012-6019.
47. Fickenscher, H., Bokel, C., Knappe, A., Biesinger, B., Meinl, E., Fleischer, B., Fleckenstein, B. & Broker, B. M. (1997). Functional phenotype of transformed human αβ and γδ T cells determined by different subgroup C strains of herpesvirus saimiri. J Virol 71, 2252-2263.
48. Flano, E., Kim, I.-J., Woodland, D. & Blackman, M. A. (2002). γ-Herpesvirus latency is preferentially maintained in splenic germinal center and memory B cells. J Exp Med 196, 1363-1372.
49. + T-cell response to an Epstein-Barr virus-related gammaherpesvirus infecting rhesus macaques provides evidence for immune evasion by the EBNA1-homolgue. J Virol 79, 12681-12691.
50. Fowler, P., Marques, S., Simas, J. P. & Efstathiou, S. (2003). ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency. J Gen Virol 84, 3405-3416.
51. Ganem, D. (2007). Kaposi's sarcoma-associated herpesvirus. In Fields Virology, 5th edn, pp. 2847-2888. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
52. Gao, S.-J., Zhang, Y.-J., Deng, J.-H., Rabkin, C. S., Flore, O. & Jenson, H. B. (1999). Molecular polymorphism of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen: evidence for a large repertoire of viral genotypes and dual infection with different viral genotypes. J Infect Dis 180, 1466-1476.
53. Gao, J., Coulson, J. M., Whitehouse, A. & Blake, N. (2009). Reduction in RNA levels rather than retardation of translation is responsible for the inhibition of major histocompatibility complex class I antigen presentation by the glutamic acid-rich repeat of herpesvirus saimiri open reading frame 73. J Virol 83, 273-282
54. Garneau, N. L., Wilusz, J. & Wilusz, C. J. (2007). The highways and byways of mRNA decay. Nat Rev Mol Cell Biol 8, 113-126.
55. Greensill, J., Sheldon, J. A., Renwick, N. M., Beer, B. E., Norley, S., Goudsmit, J. & Schulz, T. F. (2000). Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among old world primates? J Virol 74, 1572-1577.
56. Griffiths, R. & Whitehouse, A. (2007). Herpesvirus saimiri episomal persistence is maintained via interaction between open reading frame 73 and the cellular chromosome-associated protein MeCP2. J Virol 81, 4021-4032.
57. Griffiths, R., Harrison, S. M., Macnab, S. & Whitehouse, A. (2008). Mapping the minimal regions within the ORF73 protein required for herpesvirus saimiri episomal persistence. J Gen Virol 89, 2843-2850.
58. Hall, K. T., Giles, M. S., Goodwin, D. J., Calderwood, M. A., Carr, I. M., Stevenson, A. J., Markham, A. F. & Whitehouse, A. (2000). Analysis of gene expression in a human cell line stably transduced with herpesvirus saimiri. J Virol 74, 7331-7337.
59. Hansen, T. H. & Bouvier, M. (2009). MHC class I antigen presentation: learning from viral evasion. Nat Rev Immunol 9, 503-513.
60. Hart, J., Ackermann, M., Jayawardane, G., Russell, G., Haig, D. M., Reid, H. & Stewart, J. P. (2007). Complete sequence and analysis of the ovine herpesvirus 2 genome. J Gen Virol 88, 28-39.
61. Heessen, S., Leonchiks, A., Issaeva, N., Sharipo, A., Selivanova, G., Masucci, M. G. & Dantuma, N. P. (2002). Functional p53 chimeras containing the Epstein-Barr virus Gly-Ala repeat are protected from Mdm2- and HPV-E6-induced proteolysis. Proc Natl Acad Sci U S A 99, 1532-1537.
62. Heessen, S., Dantuma, N. P., Tessarz, P., Jellne, M. & Masucci, M. G. (2003). Inhibition of ubiquitin/proteasome-dependent proteolysis in Saccharomyces cerevisiae by a Gly-Ala repeat. FEBS Lett 555, 397-404.
63. Hochberg, D., Middeldorp, J. M., Catalina, M., Sullivan, J. L., Luzuriaga, K. & Thorley-Lawson, D. A. (2004). Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci U S A 101, 239-244.
64. Hoyt, M. A., Zich, J., Takeuchi, J., Zhang, M., Govaerts, C. & Coffino, P. (2006). Glycine-alanine repeats impair proper substrate unfolding by the proteasome. EMBO J 25, 1720-1729.
65. Hutchings, I. A., Tierney, R. J., Kelly, G. L., Stylianou, J., Rickinson, A. B. & Bell, A. I. (2006). Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis using novel EBV-positive Burkitt and lymphoblastoid cell lines. J Virol 80, 10700-10711.
66. Johannsen, E., Calderwood, M., Kang, M.-S., Zhao, B., Portal, D. & Kieff, E. (2009). Epstein-Barr virus latent infection nuclear proteins: genome maintenance and regulation of lymphocyte cell growth and survival. In DNA Tumor Viruses, pp. 317-353. Edited by B. Damania & J. M. Pipas. New York: Springer.
67. Jung, J. U. & Desrosiers, R. C. (1991). Identification and characterization of the herpesvirus saimiri oncoprotein STP-C488. J Virol 65, 6953-6960.
68. Jung, J. U., Trimble, J. J., King, N. W., Biesinger, B., Fleckenstein, B. W. & Desrosiers, R. C. (1991). Identification of transforming genes of subgroup A and C strains of Herpesvirus saimiri. Proc Natl Acad Sci U S A 88, 7051-7055.
69. Kapoor, P., Lavoie, B. D. & Frappier, L. (2005). EBP2 plays a key role in Epstein-Barr virus mitotic segregation and is regulated by aurora family kinases. Mol Cell Biol 25, 4934-4945.
70. Kaschka-Dierich, C., Werner, F. J., Bauer, I. & Fleckenstein, B. (1982). Structure of non-integrated, circular Herpesvirus saimiri and Herpesvirus ateles genomes in tumor cell lines and in vitrotransformed cells. J Virol 44, 295-310.
71. Kedes, D. H., Lagunoff, M., Renne, R. & Ganem, D. (1997). Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J Clin Invest 100, 2606-2610.
72. Kellam, P., Boshoff, C., Whitby, D., Matthews, S., Weiss, R. A. & Talbot, S. J. (1997). Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J Hum Virol 1, 19-29.
73. Khanna, R., Burrows, S. R., Kurilla, M. G., Jacob, C. A., Misko, I. S., Sculley, T. B., Kieff, E. & Moss, D. J. (1992). Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development. J Exp Med 176, 169-176.
74. Kieff, E. & Rickinson, A. B. (2007). Epstein-Barr virus and its replication. In Fields Virology, 5th edn, pp. 2603-2654. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
75. n repeats on RNA synthesis and stability. Nucleic Acids Res 35, 1075-1084.
76. Kwun, H. J., Ramos da Silva, S., Shah, I. M., Blake, N., Moore, P. S. & Chang, Y. (2007). Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing. J Virol 81, 8225-8235.
77. Lacoste, V., Mauclere, P., Dubreuil, G., Lewis, J., Georges-Courbot, M.-C. & Gessain, A. (2000). KSHV-like herpesviruses in chimps and gorillas. Nature 407, 151-152.
78. Lacoste, V., Mauclere, P., Dubreuil, G., Lewis, J., Georges-Courbot, M.-C. & Gessain, A. (2001). A novel gamma 2-herpesvirus of the rhadinovirus 2 lineage in chimpanzees. Genome Res 11, 1511-1519.
79. Lee, S. P., Brooks, J. M., Al-Jarrah, H., Thomas, W. A., Haigh, T. A., Taylor, G. S., Humme, S., Schepers, A., Hammerschmidt, W. & other authors (2004). CD8 T cell recognition of endogenously expressed Epstein-Barr virus nuclear antigen 1. J Exp Med 199, 1409-1420.
80. + T-helper 1 responses. J Virol 75, 8649-8659.
81. Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G. & Masucci, M. G. (1995). Inhibition of antigen processing by the internal repeat region of Epstein-Barr virus nuclear antigen-1. Nature 375, 685-688.
82. Levitskaya, J., Sharipo, A., Leonchikis, A., Ciechanover, A. & Masucci, M. G. (1997). Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci U S A 94, 12616-12621.
83. Lindner, S. E. & Sugden, B. (2007). The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells. Plasmid 58, 1-12.
84. Lomonte, P., Bublot, M., van Santen, V., Keil, G. M., Pastoret, P. & Thiry, E. (1995). Analysis of bovine herpesvirus 4 genomic regions located outside the conserved gammaherpesvirus gene blocks. J Gen Virol 76, 1835-1841.
85. Mackay, L. K., Long, H. M., Brooks, J. M., Taylor, G. S., Leung, C. S., Chen, A., Wang, F. & Rickinson, A. B. (2009). T cell detection of a B-cell tropic virus infection: newly-synthesised versus mature viral proteins as antigen sources for CD4 and CD8 epitope display. PLoS Pathog 5, e1000699.
86. Marechal, V., Dehee, A., Chikhi-Brachet, R., Piolot, T., Coppey-Moisan, M. & Nicolas, J. C. (1999). Mapping EBNA-1 domains involved in binding to metaphase chromosomes. J Virol 73, 4385-4392.
87. Marques, S., Efstathiou, S., Smith, K. G., Haury, M. & Simas, J. P. (2003). Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes. J Virol 77, 7308-7318.
88. Medveczky, P., Szomolanyi, E., Desrosiers, R. C. & Mulder, C. (1984). Classification of herpesvirus saimiri into three groups based on extreme variation in a DNA region required for oncogenicity. J Virol 52, 938-944.
89. Medveczky, M. M., Szomolanyi, E., Hesselton, R., DeGrand, D., Geck, P. & Medveczky, P. G. (1989). Herpesvirus saimiri strains from three DNA subgroups have different oncogenic potentials in New Zealand white rabbits. J Virol 63, 3601-3611.
90. Mesri, E. A., Cesarman, E., Arvanitakis, L., Rafii, S., Moore, M. A., Posnett, D. N., Knowles, D. M. & Asch, A. S. (1996). Human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 183, 2385-2390.
91. Moghaddam, A., Rosenzweig, M., Lee-Parritz, D., Annis, B., Johnson, R. P. & Wang, F. (1997). An animal model for acute and persistent Epstein-Barr virus infection. Science 276, 2030-2033.
92. Moorman, N. J., Willer, D. O. & Speck, S. H. (2003). The gammaherpesvirus 68 latency-associated nuclear antigen homolog is critical for the establishment of splenic latency. J Virol 77, 10295-10303.
93. Murray, R. J., Kurilla, M. G., Brooks, J. M., Thomas, W. A., Rowe, M., Kieff, E. & Rickinson, A. B. (1992). Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med 176, 157-168.
94. Nash, A. A., Dutia, B. M., Stewart, J. P. & Davison, A. J. (2001). Natural history of murine c-herpesvirus infection. Philos Trans R Soc Lond B Biol Sci 356, 569-579.
95. Nayyar, V. K., Shire, K. & Frappier, L. (2009). Mitotic chromosome interactions of Epstein-Barr nuclear antigen 1 (EBNA1) and human EBNA1-binding protein 2 (EBP2). J Cell Sci 122, 4341-4350.
96. Niederman, J. C., McCollum, R. W., Henle, G. & Henle, W. (1968). Infectious mononucleosis: clinical manifestations in relation to EB virus antibodies. JAMA 203, 205-209.
97. Ossevoort, M., Zaldumbide, A., te Velthuis, A. J. W., Melchers, M., Ressing, M. E., Wiertz, E. J. H. J. & Hoeben, R. C. (2007). The nested open reading frame in the Epstein-Barr virus nuclear antigen-1 mRNA encodes a protein capable of inhibiting antigen presentation in cis. Mol Immunol 44, 3588-3596.
98. Paludan, C., Schmid, D., Landthaler, M., Vockerodt, M., Kube, D., Tuschl, T. & Munz, C. (2005). Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307, 593-596.
99. Pamer, E. & Cresswell, P. (1998). Mechanisms of MHC class Irestricted antigen processing. Annu Rev Immunol 16, 323-358.
100. Pandolfo, M. (2002). The molecular basis of Friedreich ataxia. Adv Exp Med Biol 516, 99-118.
101. Rainbow, L., Platt, G., Simpson, G., Sarid, R., Gao, S., Stoiber, H., Herrington, C., Moore, P. & Schulz, T. (1997). The 222- to 234-kilodalton latent nuclear antigen (LNA) of Kaposi's sarcomaassociated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 71, 5915-5921.
102. Rawlins, D. R., Milman, G., Hayward, S. D. & Hayward, G. S. (1985). Sequence specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42, 859-868.
103. Reisman, D., Yates, J. & Sugden, B. (1985). A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components. Mol Cell Biol 5, 1822-1832.
104. Renne, R., Lagunoff, M., Zhong, W. & Ganem, D. (1996). The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J Virol 70, 8151-8154.
105. Rickinson, A. B. & Kieff, E. (2007). Epstein-Barr virus. In Fields Virology, 5th edn, pp. 2655-2700. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
106. Rickinson, A. B. & Moss, D. M. (1997). Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol 15, 405-431.
107. Rivailler, P., Cho, Y.-G. & Wang, F. (2002). Complete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a New World primate: a defining point in the evolution of oncogenic lymphocryptoviruses. J Virol 76, 12055-12068.
108. Rivas, C., Thlick, A. E., Parravicini, C., Moore, P. S. & Chang, Y. (2001). Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol 75, 429-438.
109. Roizman, B., Knipe, D. M. & Whitley, R. J. (2007). Herpes simplex viruses. In Fields Virology, 5th edn, pp. 2501-2601. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
110. Ruf, I. K., Moghaddam, A., Wang, F. & Sample, J. (1999). Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates. J Virol 73, 1980-1989.
111. Russo, J. J., Bohenzky, R. A., Chien, M. C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S. & other authors (1996). Nucleotide sequence of the Kaposi sarcomaassociated herpesvirus (HHV8). Proc Natl Acad Sci U S A 93, 14862-14867.
112. Sadler, R., Wu, L., Forghani, B., Renne, R., Zhong, W., Herndier, B. & Ganem, D. (1999). A complex translational program generates multiple novel proteins from the latently expressed Kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J Virol 73, 5722-5730.
113. Sample, J., Henson, E. B. D. & Sample, C. (1992). The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J Virol 66, 4654-4661.
114. Schaefer, B. C., Strominger, J. L. & Speck, S. H. (1997). Host-celldetermined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs. Mol Cell Biol 17, 364-377.
115. Schultz, E. R., Rankin, G. W., Jr, Blanc, M. P., Raden, B. W., Tsai, C. C. & Rose, T. M. (2000). Characterization of two divergent lineages of macaque rhadinoviruses related to Kaposi's sarcoma-associated herpesvirus. J Virol 74, 4919-4928.
116. Searles, R. P., Berquam, E. P., Axthelm, M. K. & Wong, S. W. (1999). Sequence and genomic analysis of a rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Virol 73, 3040-3053.
117. Sears, J., Ujihara, M., Wong, S., Ott, C., Middeldorp, J. & Aiyar, A. (2004). The amino terminus of Epstein-Barr virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes. J Virol 78, 11487-11505.
118. Sharipo, A., Imreh, M., Leonchiks, A., Imreh, S. & Masucci, M. G. (1998). A minimal glycine-alanine repeat prevents the interaction of ubiquitinated IκB α with the proteasome: a new mechanism for selective inhibition of proteolysis. Nat Med 4, 939-944.
119. Sinclair, J. (2008). Human cytomegalovirus: latency and reactivation in the myeloid lineage. J Clin Virol 41, 180-185.
120. Soragni, E., Herman, D., Dent, S. Y. R., Gottesfeld, J. M., Well, R. D. & Napierala, M. (2008). Long intronic GAA.TAA repeats induce epigenetic changes and reporter gene silencing in a molecular model of Friedreich ataxia. Nucleic Acids Res 36, 6056-6065.
121. Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d'Agay, M. F., Clauvel, J. P., Raphael, M. & other authors (1995). Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276-1280.
122. Stevenson, P. G. (2004). Immune evasion by gamma-herpesviruses. Curr Opin Immunol 16, 456-462.
123. Stuber, G., Dillner, J., Modrow, S., Wolf, H., Szekely, L., Klein, G. & Klein, E. (1995). HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBAN-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1. Int Immunol 7, 653-663.
124. +, interferon-γ-secreting, T lymphocytes. Eur J Immunol 29, 3995-4001.
125. Talbot, S. J., Weiss, R. A., Kellam, P. & Boshoff, C. (1999). Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. Virology 257, 84-94.
126. Telford, E. A. R., Watson, M. S., Aird, H. C., Perry, J. & Davison, A. J. (1995). The DNA sequence of equine herpesvirus 2. J Mol Biol 249, 520-528.
127. + T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1. J Exp Med 199, 1421-1431.
128. + T cell epitopes. J Exp Med 204, 525-532.
129. + T cell epitopes. Eur J Immunol 37, 328-337.
130. Tellam, J., Smith, C., Rist, M., Webb, N., Cooper, L., Vuocolo, T., Connolly, G., Tscharke, D. C., Devoy, M. P. & Khanna, R. (2008). Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition. Proc Natl Acad Sci U S A 105, 9319-9324.
131. Thome, M., Schneider, P., Hofmann, K., Fickenscher, H., Meinl, E., Neipel, C., Mattmann, C., Burns, K., Bodmer, J. L. & other authors (1997). Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386, 517-521.
132. Thorley-Lawson, D. A. & Gross, A. (2004). Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350, 1328-1337.
133. Trivedi, P., Masucci, M. G., Winberg, G. & Klein, G. (1991). The Epstein-Barr virus-encoded membrane protein LMP1 but not the nuclear antigen EBNA-1 induces rejection of transfected murine mammary carcinoma cells. Int J Cancer 48, 794-800.
134. Verma, S. C. & Robertson, E. S. (2003). ORF73 of herpesvirus saimiri strain C488 tethers the viral genome to metaphase chromosomes and binds to cis-acting DNA sequences in the terminal repeats. J Virol 77, 12494-12506.
135. Virgin, H. W., IV, Latreille, P., Wamsley, P., Hallsworth, K., Weck, K. E., Dal Canto, A. J. & Speck, S. H. (1997). Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 71, 5894-5904.
136. Virgin, H. W., IV, Presti, R. M., Li, X.-Y., Liu, C. & Speck, S. H. (1999). Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice. J Virol 73, 2321-2332.
137. + T lymphocytes. J Exp Med 199, 459-470.
138. Wang, F., Rivailler, P., Rao, P. & Cho, Y.-G. (2001). Simian homologues of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356, 489-497.
139. Wen, K. W., Dittmer, D. P. & Damania, B. (2009). Disruption of LANA in rhesus rhadinovirus generates a highly lytic recombinant virus. J Virol 83, 9786-9802.
140. Werner, F. J., Bornkamn, G. W. & Fleckenstein, B. (1977). Episomal viral DNA in a Herpesvirus saimiri-transformed lymphoid cell line. J Virol 22, 794-803.
141. Willer, D. O. & Speck, S. H. (2003). Long-term latent murine gammaherpesvirus 68 infection is preferentially found within the surface immunoglobulin D-negative subset of splenic B cells in vivo. J Virol 77, 8310-8321.
142. Woodberry, T., Suscovich, T. J., Henry, L. M., Martin, J. N., Dollard, S., O'Connor, P. G., Davis, J. K., Osmond, D., Lee, T.-H. & other authors (2005). Impact of Kaposi's sarcoma-associated herpesvirus (KSHV) burden and HIV coinfection on the detection of T cell responses to KSHV ORF73 and ORF65 proteins. J Infect Dis 192, 622-629.
143. Yates, J. L., Warren, N. & Sugden, B. (1985). Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313, 812-815.
144. Yates, J. L., Camiolo, S. M., Ali, S. & Ying, A. (1996). Comparison of the EBNA-1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function. Virology 222, 1-13.
145. Ye, F.-C., Zhou, F.-C., Yoo, S. M., Xie, J.-P., Browning, P. J. & Gao, S.-J. (2004). Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence. J Virol 78, 11121-11129.
146. Yewdell, J. W. (2007). Plumbing the sources of endogenous MHC class I peptide ligands. Curr Opin Immunol 19, 79-86.
147. Yin, Y., Manoury, B. & Fahraeus, R. (2003). Self-inhibition of synthesis and antigen presentation by the Epstein-Barr virus-encoded EBNA1. Science 301, 1371-1374.
148. Yoshioka, M., Crum, M. M. & Sample, J. T. (2008). Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of premRNA processing. J Virol 82, 1679-1687.
149. Zaldumbide, A., Ossevoort, M., Wiertz, E. J. H. J. & Hoeben, R. C. (2007). In cis inhibition of antigen processing by the latencyassociated nuclear antigen I of Kaposi sarcoma herpes virus. Mol Immunol 44, 1352-1360.